CoChat

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

The effect of X-linked dosage compensation on complex trait variation

Open access

Published version of a preprint

Abstract

Quantitative genetics theory predicts that X-chromosome dosage compensation (DC) will have a detectable effect on the amount of genetic and therefore phenotypic trait variances at associated loci in males and females. Here, we systematically examine the role of DC in humans in 20 complex traits in a sample of more than 450,000 individuals from the UK Biobank and 1600 gene expression traits from a sample of 2000 individuals as well as across-tissue gene expression from the GTEx resource. We find approximately twice as much X-linked genetic variation across the UK Biobank traits in males (mean h 2 SNP = 0.63%) compared to females (mean h 2 SNP = 0.30%), confirming the predicted DC effect. Our DC estimates for complex traits and gene expression are consistent with a small proportion of genes escaping X-inactivation in a trait- and tissue-dependent manner. Finally, we highlight examples of biologically relevant X-linked heterogeneity between the sexes that bias DC estimates if unaccounted for.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-10598-y

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Estimates of dosage compensation (DC) ratio and dosage compensation coefficient (DCC) for the UK Biobank (UKB) traits. a DC ratio with 95% confidence intervals (DC ratio +/− 1.96*SE) for 20 UKB traits as estimated using summary statistics from the association analyses. The black points indicate the DC ratio estimated using all SNPs on the X chromosome (non-pseudoautosomal region, non-PAR). For Height, Fat%, hBMD, RBC, Hgb and Hcrit the DC ratios are re-estimated excluding the SNPs in the regions of identified heterogeneity (Supplementary Table 4) and presented as coloured points (green: excluding region 1; yellow: excluding region 2; red: excluding region 3 or 4; blue: excluding region 1 and 3 or 4). The green and red dashed lines indicate the expectations under full DC (FDC) and lack of DC (No DC), respectively. The black solid line is the mean DC ratio (=1.88) after accounting for heterogeneity. b Male and female per-allele effect estimates (in standard deviation units) (+/- SE) are compared for the lead SNPs identified in the combined discovery analysis (M = 251). The SNPs located in the regions of heterogeneity for the six traits mentioned above are excluded. The green and red dashed lines indicate the expectations under FDC and no DC, respectively. The black line represents DCC (1.85, SE = 0.04). SE, standard error. M, number of lead SNPs. Traits: standing height (Height), forced expiratory volume in 1-second (FEV1), smoking status (Smoking), hand grip strength, right (Grip), body mass index (BMI), body fat percentage (Fat%), basal metabolic rate (BMR), waist to hip ratio (WHR), diastolic blood pressure (DBP), heel bone mineral density T-score (hBMD), fluid intelligence score (FI), neuroticism score (Neuroticism), educational attainment (EA), skin colour (Skin), hair colour (Hair), white blood cell (leukocyte) count (WBC), platelet count (Platelet), red blood cell (erythrocyte) count (RBC), haemoglobin concentration (Hgb), Haematocrit percentage (Hcrit)
Fig. 1 Estimates of dosage compensation (DC) ratio and dosage compensation coefficient (DCC) for the UK Biobank (UKB) traits. a DC ratio with 95% confidence intervals (DC ratio +/− 1.96*SE) for 20 UKB traits as estimated using summary statistics from the association analyses. The black points indicate the DC ratio estimated using all SNPs on the X chromosome (non-pseudoautosomal region, non-PAR). For Height, Fat%, hBMD, RBC, Hgb and Hcrit the DC ratios are re-estimated excluding the SNPs in the regions of identified heterogeneity (Supplementary Table 4) and presented as coloured points (green: excluding region 1; yellow: excluding region 2; red: excluding region 3 or 4; blue: excluding region 1 and 3 or 4). The green and red dashed lines indicate the expectations under full DC (FDC) and lack of DC (No DC), respectively. The black solid line is the mean DC ratio (=1.88) after accounting for heterogeneity. b Male and female per-allele effect estimates (in standard deviation units) (+/- SE) are compared for the lead SNPs identified in the combined discovery analysis (M = 251). The SNPs located in the regions of heterogeneity for the six traits mentioned above are excluded. The green and red dashed lines indicate the expectations under FDC and no DC, respectively. The black line represents DCC (1.85, SE = 0.04). SE, standard error. M, number of lead SNPs. Traits: standing height (Height), forced expiratory volume in 1-second (FEV1), smoking status (Smoking), hand grip strength, right (Grip), body mass index (BMI), body fat percentage (Fat%), basal metabolic rate (BMR), waist to hip ratio (WHR), diastolic blood pressure (DBP), heel bone mineral density T-score (hBMD), fluid intelligence score (FI), neuroticism score (Neuroticism), educational attainment (EA), skin colour (Skin), hair colour (Hair), white blood cell (leukocyte) count (WBC), platelet count (Platelet), red blood cell (erythrocyte) count (RBC), haemoglobin concentration (Hgb), Haematocrit percentage (Hcrit)CC BY · PubMed Central
Fig. 2 Four regions of heterogeneity (+/−250 kb) on the X chromosome. For each trait, regions of heterogeneity were identified as all SNPs within a region of linkage disequilibrium (LD) R2 > 0.05 to the SNP with highest evidence of significant heterogeneity (Supplementary Table 4). In each region the heterogeneity P-values (PHet) are plotted (grey dots) for all traits with significant heterogeneity in that region. The top SNPs for each trait are shown in blue. The genes discussed in the Supplementary Note 2 are highlighted in red. In region 3, only the ALAS2 gene and genes with X-chromosome position > 56 Mb are shown for simplicity (the omitted 15 genes are: ITIH6, MAGED2, TRO, PFKFB1, APEX2, PAGE2B, PAGE2, FAM104B, MTRNR2L10, PAGE5, PAGE3, MAGEH1, USP51, FOXR2, RRAGB). The red dashed line represents the significance threshold (PHet = 5.0 × 10–8). The green dashed lines represent the boundaries of the regions. Traits: Haematocrit percentage (Hcrit), haemoglobin concentration (Hgb), red blood cell (erythrocyte) count (RBC), heel bone mineral density T-score (hBMD), body fat percentage (Fat%), standing height (Height)
Fig. 2 Four regions of heterogeneity (+/−250 kb) on the X chromosome. For each trait, regions of heterogeneity were identified as all SNPs within a region of linkage disequilibrium (LD) R2 > 0.05 to the SNP with highest evidence of significant heterogeneity (Supplementary Table 4). In each region the heterogeneity P-values (PHet) are plotted (grey dots) for all traits with significant heterogeneity in that region. The top SNPs for each trait are shown in blue. The genes discussed in the Supplementary Note 2 are highlighted in red. In region 3, only the ALAS2 gene and genes with X-chromosome position > 56 Mb are shown for simplicity (the omitted 15 genes are: ITIH6, MAGED2, TRO, PFKFB1, APEX2, PAGE2B, PAGE2, FAM104B, MTRNR2L10, PAGE5, PAGE3, MAGEH1, USP51, FOXR2, RRAGB). The red dashed line represents the significance threshold (PHet = 5.0 × 10–8). The green dashed lines represent the boundaries of the regions. Traits: Haematocrit percentage (Hcrit), haemoglobin concentration (Hgb), red blood cell (erythrocyte) count (RBC), heel bone mineral density T-score (hBMD), body fat percentage (Fat%), standing height (Height)CC BY · PubMed Central
Fig. 3 Dosage compensation coefficient (DCC) for eQTLs from blood samples. Comparison of per-allele effects from sex-specific analyses (+/- SE) for cis-eQTLs identified in CAGE whole blood. A total of 57/74 and 40/51 eQTLs (PeQTL < 1.6 × 10–10) in males and females, respectively, had either Escape, Variable, or Inactive status using annotations from10. For 41 inactive eQTLs in the male discovery, DCC is 2.03 (SE = 0.05), and for 16 escape or variable escape eQTLs, DCC is 2.05 (SE = 0.10). For 30 inactive eQTLs in the female discovery, DCC is 1.95 (SE = 0.05), and for 10 escape or variable escape eQTLs, DCC is 1.86 (SE = 0.10). The red dashed line represents the expectation under the escape from X chromosome inactivation (XCI) model. The green dashed line represents the expectation under full dosage compensation model. The black line is the regression line. SE, standard error
Fig. 3 Dosage compensation coefficient (DCC) for eQTLs from blood samples. Comparison of per-allele effects from sex-specific analyses (+/- SE) for cis-eQTLs identified in CAGE whole blood. A total of 57/74 and 40/51 eQTLs (PeQTL < 1.6 × 10–10) in males and females, respectively, had either Escape, Variable, or Inactive status using annotations from10. For 41 inactive eQTLs in the male discovery, DCC is 2.03 (SE = 0.05), and for 16 escape or variable escape eQTLs, DCC is 2.05 (SE = 0.10). For 30 inactive eQTLs in the female discovery, DCC is 1.95 (SE = 0.05), and for 10 escape or variable escape eQTLs, DCC is 1.86 (SE = 0.10). The red dashed line represents the expectation under the escape from X chromosome inactivation (XCI) model. The green dashed line represents the expectation under full dosage compensation model. The black line is the regression line. SE, standard errorCC BY · PubMed Central
Fig. 4 Dosage compensation coefficient (DCC) for eQTLs across tissues. DCC is estimated for tissues with at least three eQTLs that satisfied the within tissue Bonferroni significance threshold in each of the 22 tissue-types. A mean of 28 (SD = 18) eQTL are identified in the male discovery analysis giving a mean DCC of 1.94 (SD = 0.16) across 22 tissues. A mean of 5 (SD = 0.82) eQTLs are identified in the female discovery analysis giving mean DCC of 1.59 (SD = 0.13) across seven tissues. The coloured bars represent the standard errors. Males were down-sampled 100 times so that the proportions match that of females within each of the seven tissues, and mean DCC is calculated across the 100 replicates. The grey bars represent the standard deviation across 100 replicates. SD, standard deviation
Fig. 4 Dosage compensation coefficient (DCC) for eQTLs across tissues. DCC is estimated for tissues with at least three eQTLs that satisfied the within tissue Bonferroni significance threshold in each of the 22 tissue-types. A mean of 28 (SD = 18) eQTL are identified in the male discovery analysis giving a mean DCC of 1.94 (SD = 0.16) across 22 tissues. A mean of 5 (SD = 0.82) eQTLs are identified in the female discovery analysis giving mean DCC of 1.59 (SD = 0.13) across seven tissues. The coloured bars represent the standard errors. Males were down-sampled 100 times so that the proportions match that of females within each of the seven tissues, and mean DCC is calculated across the 100 replicates. The grey bars represent the standard deviation across 100 replicates. SD, standard deviationCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Cited by

See all 82

Metadata

Authors
Sidorenko, J., Kassam, I., Kemper, K. E., Zeng, J., Lloyd-Jones, L. R., Montgomery, G. W., Gibson, G., Metspalu, A., Esko, T., Yang, J., McRae, A. F., & Visscher, P. M.
Affiliations
  • The University of Queensland (AU)
  • Georgia Institute of Technology (US)
  • University of Tartu (EE)
Corresponding author
  • Sidorenko, Julia
  • Visscher, Peter M.
Venue
Nature Communications
Published
2019-07-08
Volume
10
Issue
1
Pages
3009-3009
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2956222947
Cited by
82
References
85
Citations by year
2026: 4 · 2025: 11 · 2024: 15 · 2023: 18 · 2022: 5 · 2021: 17 · 2020: 7 · 2019: 5
FWCI
5.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Department of Health | National Health and Medical Research Council (1113400)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
Keywords
X chromosome inactivation, complex traits, heritability, gene expression traits, sex-biased gene expression, UK Biobank, GTEx
MeSH terms
Female, Humans, Male, Models, Genetic, Phenotype, Sex Factors, Genetic Variation, Multifactorial Inheritance, X Chromosome Inactivation, Genes, X-Linked, Genome-Wide Association Study, Genetic Loci, Datasets as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of X-linked dosage compensation on complex trait variation. https://app.cochat.ai/papers/10.1038/s41467-019-10598-y
The paper
Sidorenko, J., Kassam, I., Kemper, K. E., Zeng, J., Lloyd-Jones, L. R., Montgomery, G. W., Gibson, G., Metspalu, A., Esko, T., Yang, J., McRae, A. F., & Visscher, P. M. (2019). The effect of X-linked dosage compensation on complex trait variation. Nature Communications. https://doi.org/10.1038/s41467-019-10598-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.